New drug submissions are one thing, and that's what the veterinary drugs directorate deals with. The other part that we face challenges with is keeping the drugs that we have registered on the market here, and that's what the regulatory operations enforcement branch deals with.
In terms of trying to bring drugs to the market here that are already on the market in the United States, we don't have the ability to have any kind of joint reviews, nor do we have the ability to essentially grandfather in or recognize foreign approvals by the USDA or the European Medicines Agency. That would be really beneficial in cutting down both the time it takes to register something that's already registered somewhere else and, probably, the costs that would be associated with doing a complete review of something that regulatory authorities we consider to be trusted regulators have already done.